Intensive Versus Conventional Digoxin Use in Patients With Heart Failure
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT02797145
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 200 participants
- Sponsor
- Hospital Ana Nery
- Registry
-
NCT02797145
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Brazil
- Registry status
- Unknown status
Technical summary
Registry record NCT02797145. Randomized; no masking; primary purpose treatment. Start 2016-05 (registry gives no type); primary completion 2018-05 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Intensive Versus Conventional Digoxin Use in Patients With Heart Failure
- Acronym
- ICHF
- Condition
- Heart Failure
- Intervention (Drug)
- Digoxin dose-adjusted
- Intervention (Drug)
- Standard dose
- Lead sponsor
- Hospital Ana Nery
Record details
- Record id
cardio:ct-nct02797145- Content hash
b8e9c42bfe3e845fc5a8018fbac357703fdcf6a12a6a241767e2ed4eba1f1335